Targeted Medical Pharma Inc. (TRGM) OTC MARKETS
$0 - (-)
Market Cap: $2947
As of 07/27/23 12:00 AM EDT. Market closed.
Targeted Medical Pharma Inc. (TRGM)
OTC MARKETS
$0
- (-)
Market Cap: $2947
As of 07/27/23 12:00 AM EDT. Market closed.
targeted medical pharma, inc. is a publicly traded, los angeles-based biotechnology company that is committed to developing novel therapies for the safe and effective treatment of disease. the company currently develops and distributes amino acid based medical foods, a rapidly growing sector of medication technology, for the treatment of pain syndromes, peripheral neuropathy, hypertension, ... read more
targeted medical pharma, inc. is a publicly traded, los angeles-based biotechnology company that is committed to developing novel therapies for the safe and effective treatment of disease. the company currently develops and distributes amino acid based medical foods, a rapidly growing sector of medication technology, for the treatment of pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. the company also develops a line of dietary supplements designed to support health and wellness. tmp currently manufactures 10 proprietary amino acid based medical foods, and the dietary supplements clearwayz™ and theraleve™. the products are sold directly to physicians, patients and pharmacies in the united states and abroad. the company is currently developing new therapies for distribution in china, japan and the middle east. we intend to continue to develop our technology and build a diverse portfolio of products that reduce the harmful side effects of drug read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Wenkart Thomas Richard | Director | Mar 04, 2016 | Option Exercise | $0.05 | 200,000 | 10,000 | 200,000 | Mar 08, 2016, 06:09 AM |
Weems Kerry Neil | Director | Mar 04, 2016 | Option Exercise | $0.05 | 200,000 | 10,000 | 225,000 | Mar 07, 2016, 05:04 PM |
Silver David Samuel | Chief Medical Officer | Mar 04, 2016 | Option Exercise | $0.05 | 575,000 | 28,750 | 575,000 | Mar 07, 2016, 05:00 PM |
Giffoni Kim | Chief Executive Officer | Mar 04, 2016 | Option Exercise | $0.05 | 547,500 | 27,375 | 751,095 | Mar 07, 2016, 04:58 PM |
DEWALD MAURICE J | Director | Mar 04, 2016 | Option Exercise | $0.05 | 200,000 | 10,000 | 254,000 | Mar 07, 2016, 04:56 PM |
Horne William B | Chief Financial Officer | Mar 04, 2016 | Option Exercise | $0.05 | 342,500 | 17,125 | 674,038 | Mar 07, 2016, 04:15 PM |
Wenkart Thomas Richard | Director | Dec 31, 2015 | Option Exercise | $0.30 | 44,058 | 13,217 | 2,107,664 | Feb 04, 2016, 11:15 AM |
Giffoni Kim | Chief Executive Officer | Nov 24, 2015 | Sale | $0.01 | 8,580 | 129 | 2,646,668 | Nov 24, 2015, 04:42 PM |
Horne William B | Chief Financial Officer | Sep 11, 2015 | Option Exercise | $0.20 | 65,769 | 13,154 | 331,538 | Sep 15, 2015, 03:27 PM |
Giffoni Kim | Chief Executive Officer | Sep 11, 2015 | Option Exercise | $0.20 | 68,077 | 13,615 | 212,175 | Sep 15, 2015, 03:23 PM |
Wenkart Thomas Richard | Director | Jun 30, 2015 | Option Exercise | $0.30 | 40,183 | 12,055 | 2,063,606 | Aug 14, 2015, 04:50 PM |
Horne William B | Chief Financial Officer | Jun 17, 2015 | Option Exercise | $0.08 | 200,000 | 16,000 | 265,769 | Jun 19, 2015, 03:18 PM |
Horne William B | Chief Financial Officer | May 20, 2015 | Option Exercise | $0.20 | 65,769 | 13,154 | 65,769 | May 26, 2015, 06:37 PM |
Giffoni Kim | Chief Financial Officer | May 20, 2015 | Option Exercise | $0.20 | 68,077 | 13,615 | 144,098 | May 26, 2015, 06:35 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Nov 24, 2014 | Buy | $0.50 | 700 | 350 | 2,655,248 | Nov 24, 2014, 06:15 PM |
Elizabeth Charuvastra Exemption Trust | CEO & Chief Scientific Officer | Aug 12, 2014 | Sale | $0.40 | 101,035 | 40,414 | 295,473 | Aug 21, 2014, 01:41 PM |
Elizabeth Charuvastra Exemption Trust | CEO & Chief Scientific Officer | Jul 24, 2014 | Sale | $0.40 | 398,965 | 159,586 | 265,799 | Aug 21, 2014, 01:37 PM |
Shell William | CEO & Chief Scientific Officer | May 28, 2014 | Sale | $0.60 | 2,000 | 1,200 | 664,764 | May 28, 2014, 12:47 PM |
Shell William | CEO & Chief Scientific Officer | May 27, 2014 | Sale | $0.65 | 3,000 | 1,950 | 666,764 | May 27, 2014, 05:21 PM |
Shell William | CEO & Chief Scientific Officer | Apr 10, 2014 | Sale | $0.60 | 150,000 | 90,000 | 669,764 | Apr 10, 2014, 02:55 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Apr 09, 2014 | Buy | $0.83 | 5,000 | 4,170 | 76,021 | Apr 10, 2014, 02:51 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Dec 12, 2013 | Buy | $0.90 | 1,000 | 900 | 71,021 | Dec 16, 2013, 06:26 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Dec 11, 2013 | Buy | $0.88 | 1,000 | 880 | 70,021 | Dec 11, 2013, 06:27 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Dec 10, 2013 | Buy | $0.90 | 7,480 | 6,732 | 69,021 | Dec 11, 2013, 06:27 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Dec 09, 2013 | Buy | $0.83 | 3,500 | 2,905 | 61,541 | Dec 11, 2013, 06:27 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Dec 02, 2013 | Buy | $1.05 | 1,700 | 1,785 | 58,041 | Dec 04, 2013, 02:59 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Nov 29, 2013 | Buy | $1.09 | 600 | 654 | 56,341 | Dec 04, 2013, 02:59 PM |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | Nov 27, 2013 | Buy | $1.06 | 2,500 | 2,650 | 55,741 | Dec 04, 2013, 02:59 PM |
Nemiroff Arthur R. | Director | Nov 19, 2013 | Sale | $0.91 | 9,000 | 8,190 | 45,000 | Nov 25, 2013, 01:33 PM |
Shell William | CEO & Chief Scientific Officer | Sep 13, 2013 | Sale | $0.84 | 2,000 | 1,680 | 208,000 | Sep 20, 2013, 01:28 PM |
Shell William | CEO & Chief Scientific Officer | Jun 20, 2013 | Buy | $1.15 | 28,100 | 32,315 | 651,054 | Sep 04, 2013, 01:59 PM |
Shell William | CEO & Chief Scientific Officer | Apr 15, 2013 | Buy | $4.52 | 39,859 | 180,067 | 318,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 05, 2013 | Buy | $2.10 | 14,000 | 29,440 | 186,650 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 24, 2013 | Buy | $4.15 | 4,000 | 16,600 | 416,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 16, 2013 | Buy | $4.49 | 38,000 | 170,500 | 350,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 08, 2013 | Buy | $2.14 | 8,500 | 18,200 | 194,150 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 25, 2013 | Buy | $4.01 | 3,000 | 12,030 | 419,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 17, 2013 | Buy | $4.60 | 36,500 | 167,895 | 381,299 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 09, 2013 | Buy | $2.32 | 32,500 | 75,290 | 215,650 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 26, 2013 | Buy | $4.15 | 1,000 | 4,150 | 420,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 18, 2013 | Buy | $4.91 | 13,500 | 66,285 | 394,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 10, 2013 | Buy | $3.53 | 38,249 | 135,191 | 249,399 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 19, 2013 | Buy | $4.65 | 5,000 | 23,270 | 398,799 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 11, 2013 | Buy | $3.94 | 15,000 | 59,160 | 263,399 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 22, 2013 | Buy | $4.30 | 7,000 | 30,090 | 403,299 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 12, 2013 | Buy | $4.10 | 17,200 | 70,476 | 279,599 | Jul 23, 2013, 07:41 PM |
Shell William | CEO & Chief Scientific Officer | Apr 23, 2013 | Buy | $4.16 | 11,000 | 45,800 | 412,799 | Jul 23, 2013, 07:41 PM |
Owner | Relationship | Date | Value($) |
Wenkart Thomas Richard | Director | 03/04/2016 | 10,000 |
Weems Kerry Neil | Director | 03/04/2016 | 10,000 |
Silver David Samuel | Chief Medical Officer | 03/04/2016 | 28,750 |
Giffoni Kim | Chief Executive Officer | 03/04/2016 | 27,375 |
DEWALD MAURICE J | Director | 03/04/2016 | 10,000 |
Horne William B | Chief Financial Officer | 03/04/2016 | 17,125 |
Wenkart Thomas Richard | Director | 12/31/2015 | 13,217 |
Giffoni Kim | Chief Executive Officer | 11/24/2015 | 129 |
Horne William B | Chief Financial Officer | 09/11/2015 | 13,154 |
Giffoni Kim | Chief Executive Officer | 09/11/2015 | 13,615 |
Wenkart Thomas Richard | Director | 06/30/2015 | 12,055 |
Horne William B | Chief Financial Officer | 06/17/2015 | 16,000 |
Horne William B | Chief Financial Officer | 05/20/2015 | 13,154 |
Giffoni Kim | Chief Financial Officer | 05/20/2015 | 13,615 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 11/24/2014 | 350 |
Elizabeth Charuvastra Exemption Trust | CEO & Chief Scientific Officer | 08/12/2014 | 40,414 |
Elizabeth Charuvastra Exemption Trust | CEO & Chief Scientific Officer | 07/24/2014 | 159,586 |
Shell William | CEO & Chief Scientific Officer | 05/28/2014 | 1,200 |
Shell William | CEO & Chief Scientific Officer | 05/27/2014 | 1,950 |
Shell William | CEO & Chief Scientific Officer | 04/10/2014 | 90,000 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 04/09/2014 | 4,170 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 12/12/2013 | 900 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 12/11/2013 | 880 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 12/10/2013 | 6,732 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 12/09/2013 | 2,905 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 12/02/2013 | 1,785 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 11/29/2013 | 654 |
Giffoni Kim | EVP Foreign Sales/Inv. Rel. | 11/27/2013 | 2,650 |
Nemiroff Arthur R. | Director | 11/19/2013 | 8,190 |
Shell William | CEO & Chief Scientific Officer | 09/13/2013 | 1,680 |
Shell William | CEO & Chief Scientific Officer | 06/20/2013 | 32,315 |
Shell William | CEO & Chief Scientific Officer | 04/15/2013 | 180,067 |
Shell William | CEO & Chief Scientific Officer | 04/05/2013 | 29,440 |
Shell William | CEO & Chief Scientific Officer | 04/24/2013 | 16,600 |
Shell William | CEO & Chief Scientific Officer | 04/16/2013 | 170,500 |
Shell William | CEO & Chief Scientific Officer | 04/08/2013 | 18,200 |
Shell William | CEO & Chief Scientific Officer | 04/25/2013 | 12,030 |
Shell William | CEO & Chief Scientific Officer | 04/17/2013 | 167,895 |
Shell William | CEO & Chief Scientific Officer | 04/09/2013 | 75,290 |
Shell William | CEO & Chief Scientific Officer | 04/26/2013 | 4,150 |
Shell William | CEO & Chief Scientific Officer | 04/18/2013 | 66,285 |
Shell William | CEO & Chief Scientific Officer | 04/10/2013 | 135,191 |
Shell William | CEO & Chief Scientific Officer | 04/19/2013 | 23,270 |
Shell William | CEO & Chief Scientific Officer | 04/11/2013 | 59,160 |
Shell William | CEO & Chief Scientific Officer | 04/22/2013 | 30,090 |
Shell William | CEO & Chief Scientific Officer | 04/12/2013 | 70,476 |
Shell William | CEO & Chief Scientific Officer | 04/23/2013 | 45,800 |